Exelixis vs. Merck: Which Oncology Stock Is a Better Pick as of Now?

Exelixis, Inc. (EXEL) is an oncology-focused biotechnology company that primarily focuses on the discovery, development and commercialization of new drugs for the treatment of difficult-to-treat cancers.Pharma giant Merck (MRK) has a strong and diverse portfolio with a strong presence in oncology, along with other therapeutic areas like immunology and diabetes,...